North America bronchiectasis market is projected to register a CAGR of 6.1% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation:
North America Bronchiectasis Market, By Disease Type (CF Bronchiectasis and Non-CF Bronchiectasis), Severity (Mild to Moderate and Moderate-to-Severe), Type (Diagnosis and Treatment), Drugs Type (Branded and Generics), Route of Administration (Oral, Parenteral and Inhalation), End User (Hospitals, Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country(U.S., Canada, Mexico) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of North America bronchiectasis market are:
Technological advancement for disease testing
Rising awareness for prevention of bronchiectasis in primary and secondary care
Market Players:
The key market players for North America bronchiectasis market are listed below:
Abbott
HERSILL
Home Oxygen Company
Inogen, Inc.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
Medline Industries, Inc
Ache Laboratories Farmaceuticos S.A.
Horizon Therapeutics plc
Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
Trudell Medical International
GlaxoSmithKline plc.
AstraZeneca
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Bayer AG
Dr. Reddys Laboratories Ltd.
Sunovion Pharmaceuticals Inc. (a subsidiary of Sumitomo Dainippon Pharma Co., Ltd.)
Viatris Inc.
Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
Cipla Inc.
Electromed, Inc.
Trudell Medical International
TABLE OF CONTENT
Segmentation
Short Description
North America Bronchiectasis Market, By Disease Type (CF Bronchiectasis and Non-CF Bronchiectasis), Severity (Mild to Moderate and Moderate-to-Severe), Type (Diagnosis and Treatment), Drugs Type (Branded and Generics), Route of Administration (Oral, Parenteral and Inhalation), End User (Hospitals, Clinics, Home Healthcare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country(U.S., Canada, Mexico) Industry Trends and Forecast to 2028
Market Definition:
Bronchiectasis is a term derived from Greek word bronckos which means airways and ectasis means widening. It is a chronic lung condition which is defined as abnormal and irreversible dilation of the bronchi in which both the muscular and elastic tissues are destroyed due to short-term and long-term infection. The combination of these infections leads to one or both lungs damage. The damage site is diagnosed by high resolution computed tomography (HRCT) scan in which it shows that the larger airways are mostly affected and in the smaller airways, the disease are not scanned thats why some of the patients deals with symptoms for many years before the diagnosis.
Market Segmentation:
The bronchiectasis market is segmented on the basis of the disease type, severity, type, drugs type, route of administration, end user and distribution channel.
Market Players
The key market players for North America bronchiectasis market are listed below:
Abbott
HERSILL
Home Oxygen Company
Inogen, Inc.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Teva Pharmaceutical USA Inc. (A Subsidiary of Teva Pharmaceutical Industries Ltd.)
Medline Industries, Inc
Ache Laboratories Farmaceuticos S.A.
Horizon Therapeutics plc
Janssen Pharmaceuticals, Inc. (A Subsidiary of Johnson & Johnson Services, Inc.)
Trudell Medical International
GlaxoSmithKline plc.
AstraZeneca
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Novartis AG
Sun Pharmaceutical Industries Ltd.
Bayer AG
Dr. Reddys Laboratories Ltd.
Sunovion Pharmaceuticals Inc. (a subsidiary of Sumitomo Dainippon Pharma Co., Ltd.)
Viatris Inc.
Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
Cipla Inc.
Electromed, Inc.
Trudell Medical International
Methodology
Why Choose Us
24 * 7 Access to Analyst :
Get your pre and post sales queries resolved by our Subject matter experts.
Customization :
We will assist you to customize the report to fit your research needs.
Assured Quality :
Our prime focus is to provide qualitative and accurate data.
Free sample report :
Feel free to order a sample report before purchase.
Security :
Your personal and confidential information is safe and secured.
